The company uses its knowledge of the human microbiome to design targeted microbial therapeutics and companion diagnostics for the prevention and treatment of inflammatory diseases. Siolta Therapeutics focuses on understanding early-life microbial networks that promote healthy gut microbiome development to prevent immune dysfunction in childhood. The company is based in San Carlos, CA and is currently in the clinical stage of development.